Abstract
Background: Cervical cancer was the second most common cancer among women 15-44 years of age and in 2018 it was the fourth most frequent cancer and cause of cancer death among all women in the world
 Methods:Women (18-65 yrs) attending Department of Obstetrics and Gynaecology, SMS Medical College, Jaipur were recruited for study. After applying inclusion and exclusion criteria written and informed consent were taken from all study participants
 Results: On histopathology report we found that 10% had normal inflammation followed by 9.33% had carcinoma in situ, 8% had CIN-2, 6.67% had CIN-1, 5.67% had CIN-3 and Squamous cell carcinoma each.
 Conclusion: Pap smear and colposcopy both the tests can be used to complement each other in a hospital based screening programme, where facilities for both modalities are available. Hence use of single visit approach in which cytology, colposcopy and guided biopsy all are done in single sitting, and treated accordingly in resource poor countries like ours will enable maximal utilization of scarce medical resources.
 Keywords: Pap smear, CIN, Cervical cancer
Highlights
Cervical cancer was the second most common cancer among women 15-44 years of age and in 2018 it was the fourth most frequent cancer and cause of cancer death among all women in the world[1]
After applying inclusion and exclusion criteria written and informed consent were taken from all study participants Results: On histopathology report we found that 10% had normal inflammation followed by 9.33% had carcinoma in situ, 8% had cervical intraepithelial neoplasia (CIN)-2, 6.67% had CIN-1, 5.67% had CIN-3 and Squamous cell carcinoma each
Use of single visit approach in which cytology, colposcopy and guided biopsy all are done in single sitting, and treated in resource poor countries like ours will enable maximal utilization of scarce medical resources
Summary
Cervical cancer was the second most common cancer among women 15-44 years of age and in 2018 it was the fourth most frequent cancer and cause of cancer death among all women in the world[1]. More than half a million women were diagnosed and over a quarter of a million women died of cervical cancer in 2018, with over 85% of these women living in low resource countries, with low and medium human development indexes[2,3] These countries were predominately located in sub-Saharan Africa, Central and South America, and Asia[4]. These low resource areas bearing the brunt of the cervical disease burden mirror areas with low healthcare provider (physician, nurse, midwife) to population ratios, with 85% of WHO member states having less than one physician per 1,000 population[5].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
